Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study

Radiotherapy and Oncology

Volumn 92, Issue 1, 2009, Pages 83-88

  Taylor, Roger E ^a   Donachie, Paul H J ^b   Weston, Claire L ^b   Robinson, Kathryn J ^b   Lucraft, Helen ^c   Saran, Frank ^d   Ellison, David W ^e   Ironside, James ^f   Walker, David A ^g   Pizer, Barry L ^h  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b Children's Cancer and Leukaemia Group Data Centre   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e St Judes Children's Research Hospital   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^h ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Quality assurance; Radiotherapy; Recurrence; Supratentorial primitive neuro ectodermal tumour; Survival

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINX; MULTIPLE CYCLE TREATMENT; NEUROECTODERM TUMOR; OVERALL SURVIVAL; PINEAL BODY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; SCHOOL CHILD; SKULL; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE; X RAY FILM;

ADOLESCENT; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEUROECTODERMAL TUMORS, PRIMITIVE; RADIATION DOSAGE; SUPRATENTORIAL NEOPLASMS; TREATMENT OUTCOME;

EID: 66949112467     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.02.017     Document Type: Article

References (24)

1. Rorke L.B. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumours. J Neuropathol Exp Neurol 42 (1983) 1-15
2. Dirks P.B., Harris L., Hoffman H.J., et al. Supratentorial primitive neuroectodermal tumours in children. J Neurooncol 29 (1996) 75-84
3. Kuhl J., Muller H.L., Berthold F., et al. Preradiation chemotherapy of children and young adults with malignant brain tumours: results of the German pilot trial HIT'88./'89. Klin Pediatr 210 (1998) 227-233
4. Timmermann B., Kortman R.D., Kuhl J., et al. Role of RT in the treatment of supratentorial primitive neuroectodermal tumours in childhood: results of the prospective German brain tumour trials HIT 88/89 and 91. J Clin Oncol 20 (2002) 842-849
5. Tait D.M., Thornton-Jones H., Bloom H.J., et al. Adjuvant chemotherapy for medulloblastoma: the first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP). Eur J Cancer 26 (1990) 464-469
6. Bailey C.C., Gnekow A., Wellek S., et al. Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the German Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 2 (1995) 166-178
7. Taylor R.E., Bailey C.C., Robinson K., et al. Results of a randomised study of pre-radiation chemotherapy vs radiotherapy alone for non-metastatic (M0-1) medulloblastoma. The SIOP/UKCCSG PNET-3 study. J Clin Oncol 21 (2003) 1581-1591
8. Taylor R.E., Bailey C.C., Robinson K.J., et al. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41 (2005) 727-734
9. Pizer B.L., Weston C.L., Robinson K.J., et al. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer 42 (2006) 1120-1128
10. Taylor R.E. UKCCSG Radiotherapy and Brain Tumour groups Medulloblastoma/PNET and craniospinal radiotherapy (CSRT). Report of a workshop held in Leeds 30.6.99. Clin Oncol 13 (2001) 58-64
11. Freeman C.R., Taylor R.E., Kortmann R.-.D., and Carrie C. Radiotherapy for medulloblastoma in children: an international perspective on current clinical research efforts. Med Pediatr Oncol 39 (2002) 99-108
12. Carrie C., Alapetite C., Mere P., et al. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group. Radiother Oncol 24 (1992) 77-81
13. Carrie C., Hoffstetter S., Gomez F., et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 45 (1999) 435-439
14. Kiltie A.E., Povall J.M., and Taylor R.E. The need for the moving junction in craniospinal irradiation. Br J Radiol 73 (2000) 650-654
15. Kleihues P., Burger P.C., and Scheithauer B.W. The new WHO classification of brain tumours. Brain Pathol 3 (1993) 255-268
16. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-482
17. Taylor R.E., Lucraft H., Bailey C.C., et al. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology (SIOP)/United Kingdom Children's Cancer Study Group (UKCCSG) PNET-3 study of pre-radiotherapy chemotherapy for M0-1. Int J Radiat Oncol Biol Phys 58 (2004) 1184-1193
18. Jenkin D., Goddard K., Armstrong D., et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 19 (1990) 265-274
19. Ito S., Hoshino T., Prados M.D., and Edwards M.S. Cell kinetics of medulloblastomas. Cancer 70 (1992) 671-678
20. Packer R.J., Goldwein J., Nicholson H.S., et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children's cancer group study. J Clin Oncol 17 (1999) 2127-2136
21. Benk V., Bouhnik H., Raquin M.A., et al. Quality control of low dose craniospinal irradiation for low risk medulloblastoma. Br J Radiol 68 (1995) 1009-1013
22. Coles C.E., Hoole A.C.F., Harden S.V., et al. Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET-4 trial protocol. Radiother Oncol 69 (2003) 189-194
23. International Commission on Radiation Units 1993. ICRU 50 Report.
24. International Commission on Radiation Units 1999. ICRU 62 Report.